全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Toni K. Choueiri , Eliezer M. Van Allen ...
来源:[J].European Journal of Cancer(IF 5.061), 2020, Vol.127, pp.118-122
摘要:Abstract(#br)Cancers of unknown primary (CUP) are among the most common causes of death due to cancer, are associated with a poor prognosis and have few therapeutic options available. Molecularly-guided site-specific treatments were explored based on the assumption that CUP ...
作者:... Sumanta Pal , Thomas Powles , Toni K. Choueiri
来源:[J].European Journal of Cancer(IF 5.061), 2020, Vol.126, pp.1-10
摘要:Abstract(#br)Background(#br)Cabozantinib improved progression-free survival (PFS), overall survival (OS) and objective response rate (ORR) compared with everolimus in patients with advanced renal cell carcinoma (RCC) after prior antiangiogenic therapy in the phase III METEOR...
作者:... Ithaar Derweesh , Toni K. Choueiri , Rana R. McKay
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2020
摘要:Abstract(#br)Background(#br)A growing body of evidence suggests that age and gender play a role in cancer outcomes. The objective of this study was to investigate the effect of age and gender on survival of patients with metastatic renal cell carcinoma (RCC).(#br)Methods(#br)We c...
作者:Toni K. Choueiri , Colin Hessel ...
来源:[J].European Journal of Cancer(IF 5.061), 2018, Vol.94, pp.115-125
摘要:Abstract(#br)Background(#br)The randomised phase 2 CABOSUN trial comparing cabozantinib with sunitinib as initial therapy for advanced renal cell carcinoma (RCC) of intermediate or poor risk met the primary end-point of improving progression-free survival (PFS) as assessed b...
作者:Steven L. Chang , Toni K. Choueiri , Lauren C. Harshman
来源:[J].Urologic Oncology: Seminars and Original Investigations(IF 3.647), 2019, Vol.37 (8), pp.525-528
摘要:Abstract(#br)Cytoreductive nephrectomy (CN) was established as the standard of care for the management of metastatic renal cell carcinoma (mRCC) in the early 2000s. Since that time, systemic therapeutic options for mRCC have rapidly expanded and progressed. The CARMENA trial was ...
作者:... Krishnan Ramaswamy , Toni K. Choueiri , Daniel Y.C. Heng
来源:[J].Clinical Genitourinary Cancer(IF 1.429), 2019
摘要:Abstract(#br)Background(#br)The present retrospective, longitudinal cohort study assessed the association between the first-line sunitinib treatment duration and clinical outcomes with second-line immuno-oncology (IO) therapy among patients with metastatic renal cell carcino...
作者:Toni K. Choueiri , Guru P. Sonpavde ...
来源:[J].Urologic Oncology: Seminars and Original Investigations(IF 3.647), 2018, Vol.36 (5), pp.238.e7-238.e17
摘要:Abstract(#br)Objectives(#br)Healthcare for racial minorities is densely concentrated at a small subset of hospitals in the United States. Understanding long-term outcomes at these minority-serving hospitals is highly relevant to elucidating the sources of racial disparities ...
作者:Toni K. Choueiri , Quoc-Dien Trinh ...
来源:[J].International Journal of Radiation Oncology, Biology, Physics(IF 4.524), 2017
摘要:Purpose(#br)Androgen deprivation therapy (ADT) is not recommended for low-risk prostate cancer because of its lack of benefit and potential for harm. We evaluated the incidence and predictors of ADT use in low-risk disease.(#br)Methods and Materials(#br)Using the National Ca...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×